Methadone treatment: Hepatitis infection and liver
Mavroides N,Douzenis A, Tsaklakidou D, Petroulaki E, Kokoris C4ο International Meetingof IGSC Organisation, Athens,December 1996
Ανακοινώσεις σε διεθνή συνέδρια
Ανακοινώσεις σε διεθνή συνέδρια
High compliance rate in Methadone maintenance HCV patiens with PegylatedInterferon a Plus Ribavirin than with Interferon a plus Ribavirin combination
Dimitroulopoulos D., Petroulaki E., Manolakopoulos S., AnagnostouO., Tsaklakidou D., Xinopoulos D., Tsamakidis K., Tzourmakliotis D., Paraskevas E.20th World Congress of Gastroenterology, Montreal Canada, 2005
Peginterferon /ribavirin Treatment Achieve Higher Compliance Rate inMethadone maintenance Chronic HCVinfected Patiens Than with Interferon/ribavirin Combination
Dimitris Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas106th Annual Meeting of the American Gastroenterological Association,Chicago USA,May 2005
AntiHCV treatment outcome in drug users is associatedwith buprenorfine use and adherence totreatment
Anagnostou O1,Tsirogianni E1, Goulis I2, Moursellas A1,Kollia S1, Petroulaki E1, Dimitroulopoulos D3, Micha A1, Manolakopoulos S4
OKANA- Greek Organisation AgainstDrugs, 2Aristoteleion University Of Thessaloniki Medical School,
3 Hellenic Anticancer Institute,”Saint Savvas” Hospital, 4 Athens University Medical School Latent TB infection among injection usersin methadone programs in Greece P.Katsaounou, E.Petroulaki, K.Kougianos, M.Gaggadi,G. Politis ATS May2006
Hepatitis C treatment for intravenous drugusers under substitution in real life
O.Anagnostou, E.Tsirogianni, I.Goulis, S.Kollia, E.Petroulaki, D,Dimitroulopoulos, A.Micha, A.Moursellas, S. Manolakopoulos
OKANA- Greek Organisation Against Drugs, 2 Aristoteleion University Of Thessaloniki Medical School, 3 Hellenic Anticancer Institute, “Saint Savvas” Hospital,
4 Athens University Medical School 1st International Symposium onHepatitis Care in Substance Users September 2009
ANTIHCVTREATMENT OUTCOME IN DRUG USERS IS ASSOCIATED WITH BUPRENORFINE USE ANDADHERENCE TO TREATMENT
O.Anagnostou, E.Tsirogianni, Ι.Goulis, A.Moursellas, S.Kollia, E.Petroulaki, D.Dimitroulopoulos, K.Micha, S.Manolakopoulos
2010 European Association for the Study of the Liver Treatment of chronic hepatitis C insubstitution programs: the Athens experience
O.Anagnostou, E.Petroulaki, D.Dimitroulopoulos, A.Moursellas, I.Detsi, K.Alexakou, K.Kaliva, A.Tsantilas, M.Mela, S.Manolakopoulos, M.Malliori
OKANA- Greek Organisation Against Drugs, Gastroenterology Clinic of AntiCancer Hospital of Athens “Agios Savvas”,
Gastroenterology Clinic of PoliklinikiGeneral Hospital of Athens4, Athens University Medical School 3rdInternational Symposium on Hepatitis Care in Substance Users September 2013